title: CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.
abstract: We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60-251) to 413 cells/mm(3) (IQR, 234-598) by year 5.
authors.affiliation: Fundação Oswaldo Cruz , Instituto de Nacional de Infectologia Evandro Chagas , Rio de Janeiro , Brazil.
authors.forename: Paula M
authors.initials: PM
authors.lastname: Luz
authors.affiliation: Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
authors.forename: Pablo F
authors.initials: PF
authors.lastname: Belaunzarán-Zamudio
authors.affiliation: Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
authors.forename: Brenda
authors.initials: B
authors.lastname: Crabtree-Ramírez
authors.affiliation: Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
authors.forename: Yanink
authors.initials: Y
authors.lastname: Caro-Vega
authors.affiliation: Instituto de Medicina Tropical Alexander von Humboldt , Universidad Peruana Cayetano Heredia , Lima , Peru.
authors.forename: Daniel
authors.initials: D
authors.lastname: Hoces
authors.affiliation: Vanderbilt University School of Medicine , Nashville, Tennessee.
authors.forename: Peter F
authors.initials: PF
authors.lastname: Rebeiro
authors.affiliation: Vanderbilt University School of Medicine , Nashville, Tennessee.
authors.forename: Meridith
authors.initials: M
authors.lastname: Blevins
authors.affiliation: Division of Infectious Diseases, Department of Medicine , Weill Cornell Medical College , New York.
authors.forename: Jean W
authors.initials: JW
authors.lastname: Pape
authors.affiliation: School of Medicine , University of Chile , Santiago.
authors.forename: Claudia P
authors.initials: CP
authors.lastname: Cortes
authors.affiliation: Universidad Nacional Autónoma de Honduras , Tegucigalpa.
authors.forename: Denis
authors.initials: D
authors.lastname: Padgett
authors.affiliation: Fundación Huesped , Buenos Aires , Argentina.
authors.forename: Pedro
authors.initials: P
authors.lastname: Cahn
authors.affiliation: Fundação Oswaldo Cruz , Instituto de Nacional de Infectologia Evandro Chagas , Rio de Janeiro , Brazil.
authors.forename: Valdilea G
authors.initials: VG
authors.lastname: Veloso
authors.affiliation: Vanderbilt University School of Medicine , Nashville, Tennessee.
authors.forename: Catherine C
authors.initials: CC
authors.lastname: McGowan
authors.affiliation: Fundação Oswaldo Cruz , Instituto de Nacional de Infectologia Evandro Chagas , Rio de Janeiro , Brazil.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Grinsztejn
authors.affiliation: Vanderbilt University School of Medicine , Nashville, Tennessee.
authors.forename: Bryan E
authors.initials: BE
authors.lastname: Shepherd
keywords: HIV/AIDS; Latin America and the Caribbean; cART; cohort; combination antiretroviral therapy; immune recovery; inverse probability of censoring weights